India’s COVID-19 vaccine registration for people aged 18 to 44 will go live as of 4 p.m. today (Wednesday April 28). This will be phase 3 of the vaccination campaign in India which will expand the existing criteria for vaccination of people aged 45 and over. Registration for the COVID-19 vaccination is mandatory and requires that eligible people have valid Indian proof of identity such as a PAN card or other government ID. India last reported more than 350,000 cases per day, the highest in the world.
The government will launch the registration process for people aged 18-44 at 4 p.m. via the CoWIN portal, as well as the Aarogya Setu and Umang apps, the official MyGovIndia account. tweeted Wednesday. Registration was originally announced to go live from midnight (midnight), but was postponed until 4 p.m. At the time of writing, Aarogya Setu’s official account tweeted that although registration for the CoWIN portal is now open, the scheduling of immunization sessions should be put in place by state governments and private immunization centers, so it may take a little longer before you can actually make an appointment.
Following registration, the vaccination campaign for all eligible people will start from May 1. However, it will be subject to the availability of vaccines. Appointments at government centers and private centers will depend on the number of vaccination centers ready on May 1 for vaccination of people over the age of 18, the MyGovIndia account tweeted.
How to register for the COVID-19 vaccine?
Online COVID-19 vaccination registration is mandatory for people aged 18 to 44, according to the FAQ section of the CoWIN portal. This means that unlike people aged 45 and over, people aged 18 to 44 are probably not eligible for on-site registration (walk-in appointments).
You must have a cell phone number to register for the COVID-19 vaccination online. The government also requires valid proof of Indian identity. This can be your Aadhaar card, driver’s license, PAN card, passport, pension book, NPR chip card, or voter ID card (electronic photo ID card). As mentioned, you can register on the CoWIN portal, or through the Aarogya Setu or Umang app.
Steps to register for COVID-19 vaccination via the CoWIN portal
Once registration of the COVID-19 vaccine for people aged 18 to 44 begins, eligible citizens will be able to register for an online appointment. Here is how you can do that.
Enter your mobile number and press Get OTP button. A one-time password (OTP) will reach your phone.
Enter the OTP you received on your phone and click on Check.
Now enter details like your name, gender and year of birth. Click on Register now.
Click on Schedule next to the name of the person registered to make the vaccination appointment.
Enter your PIN code and click Search. You will see the centers available for your PIN code.
You can also search for an immunization center by selecting your state and district.
Select the center, date and time of the vaccination, then press To confirm.
You can add up to four family members with a single registration. However, it is important to point out that if a person aged 45 or over and others aged between 18 and 44 wish to schedule a combined appointment, only paid private vaccination centers or vaccination centers in accordance with the state government policy will be made available. .
Steps to register for the COVID-19 vaccine via the Aarogya Setu app
If you don’t want to use the CoWIN portal through a web browser, you can use the Aarogya Setu app on your phone to sign up for the COVID-19 vaccine. Below are the steps you can follow to register using the app.
- Open the Aarogya Setu app.
- To go to the CoWIN tab from the home screen.
- To select Vaccination registration and enter your phone number to get an OTP.
- Tap Check. You will be directed to the Vaccination Registration page.
- Now follow the same steps as mentioned above to register through the CoWIN portal.
The vaccination campaign currently includes two COVID-19 vaccines, namely Covaxin which was developed by Bharat Biotech based in Hyderabad and Covishield which was developed by Oxford-AstraZeneca and is manufactured by the Serum Institute of India (SII).